MRES (Institute of Biomedical Research) FCF Yield %: -4.29 (As of Jun. 26, 2026)

What is Institute of Biomedical Research FCF Yield %?

Institute of Biomedical Research MRES FCF Yield % is -4.29 as of Jun. 26, 2026.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Institute of Biomedical Research's Trailing 12-Month Free Cash Flow is $-0.15 Mil, and Market Cap is $3.52 Mil. Therefore, Institute of Biomedical Research's FCF Yield % for today is -4.29%.

The historical rank and industry rank for Institute of Biomedical Research's FCF Yield % or its related term are showing as below:

MRES' s FCF Yield % Range Over the Past 10 Years
Min: -6.2 Med: 0 Max: 0
Current: -4.29

MRES's FCF Yield % is not ranked
in the Biotechnology industry.
Industry Median: -9.715 vs MRES: -4.29

Institute of Biomedical Research's FCF Margin % for the quarter that ended in Dec. 2010 was 0.00%.

Institute of Biomedical Research FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Institute of Biomedical Research FCF Yield % Related Terms

Institute of Biomedical Research FCF Yield % Historical Data

* Premium members only.

The historical data trend for Institute of Biomedical Research's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Institute of Biomedical Research FCF Yield % Chart

Institute of Biomedical Research Annual Data

Trend

Dec03

Dec04

Mar06

Mar07

Mar08

Mar09

Mar10

FCF Yield %

Get a 7-Day Free Trial

-0.12

-0.11

-11.01

-255.51

-4.61

Institute of Biomedical Research Quarterly Data
	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10
FCF Yield %	Get a 7-Day Free Trial															-63.11	-7.07	-0.53	-0.56	-0.10

MRES vs HSTC, NTRR, VITIF: FCF Yield % Comparison

For the Biotechnology subindustry, Institute of Biomedical Research's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Institute of Biomedical Research FCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Institute of Biomedical Research's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Institute of Biomedical Research's FCF Yield % falls into.

Save Embed

Institute of Biomedical Research FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Institute of Biomedical Research's FCF Yield % for the fiscal year that ended in Mar. 2010 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-0.24	/	5.20576
	=	-4.61%

Institute of Biomedical Research's annualized FCF Yield % for the quarter that ended in Dec. 2010 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-0.005	*	4	/	19.8843
	=	-0.10%

Frequently Asked Questions Learn more about FCF Yield % →

What does a FCF Yield % of -4.29 mean?

Institute of Biomedical Research (MRES) has a FCF Yield % of -4.29 as of Jun. 26, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Institute of Biomedical Research and its competitors.

Is Institute of Biomedical Research's FCF Yield % too high?

Institute of Biomedical Research's current FCF Yield % is -4.29.

How does Institute of Biomedical Research's FCF Yield % compare to HSTC and NTRR?

Institute of Biomedical Research's FCF Yield % of -4.29 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good FCF Yield % for a Biotechnology company?

A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high FCF Yield % mean?

A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Institute of Biomedical Research and its competitors. Institute of Biomedical Research's current FCF Yield % is -4.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Institute of Biomedical Research stock overvalued right now?

Institute of Biomedical Research (MRES) has a current FCF Yield % of -4.29. The current FCF Yield % is -4.29. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is FCF Yield % calculated?

FCF Yield % is calculated from a company's financial statements. For Institute of Biomedical Research (MRES), the current FCF Yield % is -4.29 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Institute of Biomedical Research Business Description

Industry Healthcare Biotechnology

Comparable Companies HSTC NTRR VITIF TLOG NSPX ERGO OPLI GLAG FPMI ADYNF ENTB CAPS BTHE GOVX LCAR IMUC CTBO GNBT ICOTF TIKRF

Address Dubai Science Park, 13th Floor, South Tower, Dubai, ARE, 416452

Website https://www.m2bio.co

Institute of Biomedical Research Corp is a biomedical research and development company. The company is focused on alternative plant-based food and medicine and mental health therapeutic research. The company uses brand name M2Bio Sciences engaged in deploying artificial intelligence, science and medicine, clinical research, and emerging technologies.